More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

Norovirus and the stomach flu aren't the same thing. Here's what doctors wish patients knew, from the American Medical ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load. The Japanese ...

Flu is a viral infection affecting the nose, throat and lungs, mostly during the winter months. It is far worse than an ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

But the percentage of people testing positive for HMPV out of those visiting participating GPs with symptoms of respiratory illness increased to 4.92 per cent by the middle of January 2025. This is ...